What are Tenet Healthcare's total assets?

Tenet Healthcare (THC) holds $31.2B in total assets, up 6.7% year over year.

How much debt does Tenet Healthcare have?

Tenet Healthcare carries $13.3B in total debt against $4.8B of shareholders' equity, a debt-to-equity ratio of 2.76.

How much cash does Tenet Healthcare have?

Tenet Healthcare holds $3.0B in cash and equivalents.

Can Tenet Healthcare cover its short-term obligations?

Its current ratio is 1.36 — current assets exceed current liabilities.

Where does Tenet Healthcare's balance sheet data come from?

Every line is extracted from Tenet Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Tenet Healthcare THC Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$2.97B-1.1%	$2.88B-4.5%	$2.98B-27.3%	$2.63B-8.9%	$3B+20.9%
Accounts receivable, net	$2.47B+0.2%	$2.42B+1.3%	$2.36B-3.2%	$2.38B-15.6%	$2.47B-21.7%
Inventories	$343M-0.3%	$348M+0.6%	$346M-2.8%	$338M-11.5%	$344M-12.9%
Prepaid expenses and other current assets	$351M-23.2%	$423M-76.0%	$373M+4.5%	$362M-4.5%	$457M+21.9%
Assets held for sale	$62M+195%	$62M+195%	$82M+310%	$21M0.0%	$21M-4.5%
Contract assets	$201M-0.5%	$188M-1.1%	$178M-3.8%	$191M-1.0%	$202M+4.1%
Total current assets	$8.36B+5.6%	$7.85B+2.2%	$7.81B-10.8%	$7.3B-8.3%	$7.91B+1.2%
Property and equipment, net	$6.25B+4.3%	$6.32B+4.4%	$6.09B+9.7%	$6.02B+2.9%	$5.99B+2.3%
Accumulated depreciation	$6.81B+14.6%	$6.68B+15.0%	$6.2B+8.4%	$6.1B+1.3%	$5.94B+0.6%
Goodwill	$11.39B+5.6%	$11.2B+4.7%	$11.16B+5.4%	$10.94B+1.3%	$10.79B+2.1%
Intangible assets, net	$432M-16.6%	$466M-66.6%	$462M-23.1%	$490M-23.3%	$518M-23.6%
Deferred tax assets	$199M-11.9%	$240M+5.7%	$269M+3.5%	$230M-6.1%	$226M-2.2%
Long-term investments	$3.81B+24.1%	$2.88B-5.1%	$2.94B-4.1%	$2.99B-5.1%	$3.07B-5.4%
Total assets	$31.2B+6.7%	$29.68B+2.6%	$29.42B+0.2%	$28.7B-1.9%	$29.24B+1.1%
Accounts payable	$1.34B+0.9%	$1.36B+5.1%	$1.36B+7.2%	$1.36B+7.1%	$1.33B-0.6%
Accrued expenses	$854M+20.3%	$858M-4.6%	$857M-2.5%	$793M+0.6%	$710M-8.4%
Deferred revenue	——	——	——	——	——
Current portion of long-term debt	$81M-8.0%	$79M-14.1%	$85M-10.5%	$84M-17.6%	$88M-17.8%
Income taxes payable	$236M+58.4%	$0-100%	$28M-96.6%	$25M—	$149M—
Accrued interest	$256M+3.2%	$81M-45.6%	$248M0.0%	$148M-0.7%	$248M-0.4%
Total current liabilities	$6.15B+38.2%	$4.46B+3.5%	$4.56B-17.7%	$4.27B-22.2%	$4.45B-17.8%
Long-term debt	$13.21B+0.3%	$13.17B0.0%	$13.19B+2.5%	$13.18B+2.4%	$13.17B+2.3%
Other non-current liabilities	$1.69B+2.5%	$1.71B+8.9%	$1.6B+2.6%	$1.64B-4.4%	$1.65B-2.2%
Total liabilities	$22.35B+8.6%	$20.7B+1.5%	$20.72B-2.7%	$20.4B-4.7%	$20.58B-3.1%
Common stock	262.5M0.0%	262.5M+3,181%	262.5M0.0%	262.5M0.0%	262.5M0.0%
Additional paid-in capital	$5.12B+6.2%	$4.91B+0.8%	$4.87B+0.5%	$4.86B+0.4%	$4.83B+0.4%
Retained earnings	$5.12B+49.9%	$4.42B+46.8%	$4.04B+50.3%	$3.7B+66.9%	$3.41B+74.3%
Accumulated other comprehensive income (loss)	-$179M-0.6%	-$181M-0.6%	-$174M+0.6%	-$177M0.0%	-$178M+0.6%
Treasury stock	$5.26B+35.2%	$4.94B+39.5%	$4.74B+33.9%	$4.64B+36.0%	$3.89B+23.8%
Redeemable noncontrolling interests	$2.14B-23.0%	$2.96B+8.4%	$2.92B+10.1%	$2.83B+0.5%	$2.78B+1.8%
Noncontrolling interests	$1.9B+12.0%	$1.8B+9.0%	$1.77B+11.1%	$1.73B+9.2%	$1.7B+13.8%
Total stockholders' equity	$4.81B+15.1%	$4.22B+1.2%	$4.01B+4.7%	$3.75B+7.9%	$4.18B+21.1%
Total liabilities and stockholders' equity	$31.2B+6.7%	$29.68B+2.6%	$29.42B+0.2%	$28.7B-1.9%	$29.24B+1.1%
Other current assets	$2.38B+23.3%	$1.99B+13.1%	$1.89B+11.7%	$1.78B-4.0%	$1.93B+8.7%
Finance Receivables (Current)	——	——	——	——	——
Other Receivables	$292M+24.3%	$224M-2.2%	$282M+1.4%	$264M-14.8%	$235M-25.4%
Capitalized Contract Costs, Net	——	——	——	——	——
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——	——
Finite Lived Intangible Assets - Gross	$1.81B-1.1%	$1.79B-0.7%	$1.82B-5.4%	$1.82B-7.5%	$1.83B-8.0%
Indefinite-Lived Intangible Assets	$884M+0.2%	$882M+0.3%	$886M+14.8%	$882M+14.0%	$882M+22.3%
Indefinite-Lived Intangible Assets, Gross	$884M+0.2%	$882M+0.3%	$886M+14.8%	$882M+14.0%	$882M+22.3%
Indefinite-Lived Research and Development Assets	$884M+0.2%	$882M+0.3%	$886M+14.8%	$882M+14.0%	$882M+22.3%
Indefinite-Lived Trademarks	$884M+0.2%	$882M+0.3%	$886M+14.8%	$882M+14.0%	$882M+22.3%
Intangible Assets Gross (Excluding Goodwill)	$2.69B-0.7%	$2.68B-0.3%	$2.71B+0.4%	$2.7B-1.5%	$2.71B0.0%
Deferred tax assets	$84M+7.7%	$84M+5.0%	$72M+100%	$76M-10.6%	$78M+290%
Intangible assets — net	$432M-16.6%	$466M-10.0%	$462M-23.1%	$490M-23.3%	$518M-23.6%
Other intangible assets—net	$1.32B-6.0%	$1.35B-3.5%	$1.35B-1.8%	$1.37B-2.9%	$1.4B+0.1%
Investments and long-term receivables	$3.81B+24.1%	$2.88B-5.1%	$2.94B-4.1%	$2.99B-5.1%	$3.07B-5.4%
Property, plant and equipment, net	$6.25B+4.3%	$6.32B+4.4%	$6.09B+9.7%	$6.02B+2.9%	$5.99B+2.3%
Accrued Manufacturing Costs	$854M+20.3%	$858M-4.6%	$857M-2.5%	$793M+0.6%	$710M-8.4%
Accrued Income Taxes, Current	$236M+58.4%	$0-100%	$28M-96.6%	$25M—	$149M—
Compensation and benefits	$854M+20.3%	$858M-4.6%	$857M-2.5%	$793M+0.6%	$710M-8.4%
Other accrued liabilities	$3.08B+87.0%	$1.81B+12.6%	$1.69B-12.5%	$1.57B-27.6%	$1.65B-11.7%
Current Portion of Long-Term Debt and Finance Lease Obligations	$81M-8.0%	$79M-14.1%	$85M-10.5%	$84M-17.6%	$88M-17.8%
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$89M0.0%	$94M0.0%	$79M-19.4%	$84M-17.6%	$89M-16.8%
Defined Benefit Pension Plan Liabilities (Non-Current)	$243M-18.2%	$245M-17.8%	$296M-3.9%	$297M-11.1%	$297M-11.1%
Long-Term Debt and Finance Lease Obligations	$13.13B+0.4%	$13.09B+0.1%	$13.1B+2.6%	$13.09B+2.5%	$13.08B+2.4%
Retirement and nonpension postretirement benefit obligations	$243M-18.2%	$245M-17.8%	$296M-3.9%	$297M-11.1%	$297M-11.1%
Total debt	$13.29B+0.2%	$14.96B+0.6%	$13.27B+2.4%	$13.26B+2.2%	$13.26B+2.1%
Unrecognized Tax Benefits	——	——	——	——	——
Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued	——	——	——	——	——
Common Stock Par Value Per Share	$0.050.0%	$0.050.0%	$0.050.0%	$0.050.0%	$0.050.0%
Common Stock Shares Issued	159.1M+0.5%	158.6M+0.4%	158.6M+0.4%	158.5M+0.3%	158.4M+0.4%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$8M0.0%	$8M0.0%	$8M0.0%	$8M0.0%	$8M0.0%
Capitalized Contract Cost, Net	——	——	——	——	——
Common stock, par value (in dollars per share)	$0.050.0%	$0.050.0%	$0.050.0%	$0.050.0%	$0.050.0%
Common stock, shares authorized (in shares)	$262.5M0.0%	$262.5M0.0%	$262.5M0.0%	$262.5M0.0%	$262.5M0.0%
Common stock, shares issued (in shares)	$159.13M+0.5%	$158.61M+0.4%	$158.59M+0.4%	$158.47M+0.3%	$158.41M+0.4%
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	$89M0.0%	$94M0.0%	$79M-19.4%	$84M-17.6%	$89M-16.8%
Deferred income taxes	$199M-11.9%	$240M+5.7%	$269M+3.5%	$230M-6.1%	$226M-2.2%
Estimated future recoveries	$135M—	$148M—	$153M—	$151M—	——
Finance Leases And Mortgage Notes	$636M+6.5%	$603M-0.3%	$604M+96.7%	$597M+92.0%	$597M+84.3%
Later Years	——	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	$1.38B+5.0%	$1.33B+3.1%	$1.36B+2.6%	$1.33B+0.1%	$1.31B0.0%
2028	——	——	——	——	——
2030	——	——	——	——	——
Remainder of 2026	——	——	——	——	——
2027	——	——	——	——	——
2029	——	——	——	——	——
Gross Carrying Amount	$1.81B-1.1%	$1.79B-0.7%	$1.82B-5.4%	$1.82B-7.5%	$1.83B-8.0%
Trademarks	$884M+0.2%	$882M+0.3%	$886M+14.8%	$882M+14.0%	$882M+22.3%
Indefinite- lived intangible impairment	$2.69B-0.7%	$2.68B-0.3%	$2.71B+0.4%	$2.7B-1.5%	$2.71B0.0%
Long-Term Debt and Lease Obligation	$13.13B+0.4%	$13.09B+0.1%	$13.1B+2.6%	$13.09B+2.5%	$13.08B+2.4%
Less: current maturities	$81M-8.0%	$79M-14.1%	$85M-10.5%	$84M-17.6%	$88M-17.8%
Noncontrolling interests in subsidiaries	$1.9B+12.0%	$1.8B+9.0%	$1.77B+11.1%	$1.73B+9.2%	$1.7B+13.8%
Net Cost Report Settlements Receivable (Payable) And Valuation Allowances	$0—	$1M—	-$5M—	-$5M—	——
Other	$109M-12.1%	$140M+17.6%	$115M-0.9%	$121M+18.6%	$124M+26.5%
Other receivables	$292M+24.3%	$224M-2.2%	$282M+1.4%	$264M-14.8%	$235M-25.4%
Guarantees	$162M+3.2%	$138M-28.9%	$141M-37.9%	$130M-53.6%	$157M-36.7%
Prepaid expenses	$351M-23.2%	$423M+14.9%	$373M+4.5%	$362M-4.5%	$457M+21.9%
Receivables from other government programs	$468M+11.4%	$385M+18.1%	$318M+35.3%	$361M+46.2%	$420M+75.0%
Redeemable noncontrolling interests in subsidiaries	$2.14B-23.0%	$2.96B+8.4%	$2.92B+10.1%	$2.83B+0.5%	$2.78B+1.8%
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	——	——	——	——	——
Insurance Reserve, Current	$303M+13.1%	$276M+16.0%	$287M+0.3%	$275M-2.8%	$268M+0.8%
Self-insurance accruals	$938M+7.0%	$951M+5.7%	$891M+4.2%	$873M+3.4%	$877M+10.5%
Treasury stock, shares (in shares)	$73.01M+11.4%	$71.66M+13.9%	$70.72M+12.4%	$70.12M+12.9%	$65.52M+9.0%
Unrecognized tax benefits	——	——	——	——	——
Penalties and interest accrued on unrecognized tax benefits	——	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Tenet Healthcare.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Tenet Healthcare's total assets?: Tenet Healthcare (THC) holds $31.2B in total assets, up 6.7% year over year.
How much debt does Tenet Healthcare have?: Tenet Healthcare carries $13.3B in total debt against $4.8B of shareholders' equity, a debt-to-equity ratio of 2.76.
How much cash does Tenet Healthcare have?: Tenet Healthcare holds $3.0B in cash and equivalents.
Can Tenet Healthcare cover its short-term obligations?: Its current ratio is 1.36 — current assets exceed current liabilities.
Where does Tenet Healthcare's balance sheet data come from?: Every line is extracted from Tenet Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.